Prelude Therapeutics, Inc. (PRLD)
3.23
-0.02
(-0.77%)
USD |
NASDAQ |
Nov 20, 16:00
3.22
-0.01
(-0.31%)
After-Hours: 20:00
Prelude Therapeutics Price : 3.23 for Nov. 20, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2026 | 3.21 | 3.30 | 3.17 | 3.23 | 300090.0 |
| Nov 19, 2026 | 3.34 | 3.40 | 3.21 | 3.255 | 200816.0 |
| Nov 18, 2026 | 3.32 | 3.43 | 3.28 | 3.30 | 230563.0 |
| Nov 17, 2026 | 3.39 | 3.50 | 3.26 | 3.32 | 422334.0 |
| Nov 16, 2026 | 3.32 | 3.459 | 3.28 | 3.41 | 306850.0 |
| Nov 13, 2026 | 3.53 | 3.53 | 3.27 | 3.45 | 262091.0 |
| Nov 12, 2026 | 3.73 | 3.73 | 3.50 | 3.52 | 230883.0 |
| Nov 11, 2026 | 3.80 | 4.10 | 3.73 | 3.78 | 295282.0 |
| Nov 10, 2026 | 3.68 | 3.80 | 3.51 | 3.76 | 388398.0 |
| Nov 09, 2026 | 3.65 | 3.91 | 3.51 | 3.76 | 230958.0 |
| Nov 06, 2026 | 3.48 | 3.679 | 3.34 | 3.60 | 140545.0 |
| Nov 05, 2026 | 4.09 | 4.13 | 3.55 | 3.555 | 207871.0 |
| Nov 04, 2026 | 3.84 | 4.16 | 3.74 | 4.08 | 378923.0 |
| Nov 03, 2026 | 3.87 | 4.00 | 3.76 | 3.78 | 174751.0 |
| Nov 02, 2026 | 3.91 | 4.17 | 3.73 | 3.84 | 216171.0 |
| Oct 30, 2026 | 4.02 | 4.105 | 3.82 | 3.88 | 218104.0 |
| Oct 29, 2026 | 4.16 | 4.25 | 4.07 | 4.10 | 201320.0 |
| Oct 28, 2026 | 3.89 | 4.16 | 3.79 | 4.14 | 475868.0 |
| Oct 27, 2026 | 3.70 | 3.94 | 3.60 | 3.88 | 277485.0 |
| Oct 26, 2026 | 3.63 | 3.74 | 3.40 | 3.70 | 236859.0 |
| Oct 23, 2026 | 3.59 | 3.69 | 3.41 | 3.63 | 288577.0 |
| Oct 22, 2026 | 3.61 | 3.73 | 3.47 | 3.60 | 323758.0 |
| Oct 21, 2026 | 3.56 | 3.78 | 3.473 | 3.65 | 608329.0 |
| Oct 20, 2026 | 3.40 | 3.61 | 3.35 | 3.53 | 362765.0 |
| Oct 19, 2026 | 3.28 | 3.42 | 3.26 | 3.39 | 1.589M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Q32 Bio, Inc. | 8.34 |
| Intellia Therapeutics, Inc. | 10.00 |
| Twist Bioscience Corp. | 103.32 |
| Beam Therapeutics, Inc. | 20.90 |
| Revolution Medicines, Inc. | 161.20 |
Price Related Metrics
| PS Ratio | 12.99 |
| Price to Book Value | 2.082 |
| Earnings Yield | -20.14% |
| Market Cap | 258.48M |